| Date | Title |
|---|---|
| December 8, 2020 | Progenity Announces Closing of Public Offering of Common Stock |
| December 2, 2020 | Progenity, Inc. Prices $75.0 Million Convertible Senior Notes Offering |
| December 2, 2020 | Progenity Announces Pricing of Public Offering of Common Stock |
| November 30, 2020 | Progenity Announces Proposed Convertible Senior Notes Offering |
| November 30, 2020 | Progenity Announces Proposed Public Offering of Common Stock |
| November 20, 2020 | New Test for Triaging Preeclampsia Passes Key Development Milestone: Progenity Releases Prospective Clinical Verification Data for its Preecludia™ Test |
| November 17, 2020 | Progenity to Present at 2020 San Antonio Breast Cancer Virtual Symposium |
| November 16, 2020 | Progenity to Participate in the 32nd Annual Piper Sandler Healthcare Conference |
| November 13, 2020 | Progenity to Host Preeclampsia Virtual R&D Day on November 20, 2020 |
| November 9, 2020 | Progenity Provides Corporate Updates and Reports Third Quarter 2020 Financial Results |
Displaying 71 - 80 of 117
